SEC Filing Details
Document Details
Form
Filing Date
Sep 20, 2022
Document Date
Sep 20, 2022
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
BioLineRx
Issuer
BioLineRx Ltd.
Press Releases View all
January 4, 2023
BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer
December 20, 2022
November 28, 2022
BioLineRx to Participate in the 12th Annual LifeSci Partners Corporate Access Event